In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

AbbVie pays $63bn in cash and stock for Allergan

Executive Summary

AbbVie Inc. is buying Allergan PLC for an equity value of $63bn in cash and stock. Allergan shareholders will receive $188.24 per share ($120.30 in cash and 0.8660 AbbVie shares (worth $67.94)).
Deal Industry
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Topical Delivery
      • Transdermal
    • OTC, Consumer
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Includes Contract
    • Payment Includes Stock
    • Full Acquisition

Related Companies

UsernamePublicRestriction

Register